La Story cover image

Novo Nordisk, la pilule du coupe-faim Wegovy ne passe plus en Bourse

La Story

00:00

Course aux coupe‑faim oraux

Myriam compare les avancées orales de Novo (Rybelsus/Ouigovi oral) et Lilly (nouvelle molécule).

Play episode from 18:18
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app